Low-grade non-Hodgkin lymphoma at advanced stage: A case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, retinoids, and melatonin

American Journal of Therapeutics

Volumn 14, Issue 1, 2007, Pages 113-115

  Todisco, Mauro ^a,b  

^a ASL 11   (Italy)

^b NONE   (Italy)

Author keywords

Cyclophosphamide; Melatonin; Non Hodgkin lymphoma; Retinoids; Somatostatin

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BROMOCRIPTINE; CYCLOPHOSPHAMIDE; MELATONIN; RETINOIC ACID; RETINOID; RETINOL PALMITATE; SOMATOSTATIN;

ADULT; ARTICLE; BLOOD PRESSURE; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BROMOCRIPTINE; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MELATONIN; MIDDLE AGED; RETINOIDS; SOMATOSTATIN;

EID: 33847127973     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000209675.83958.9c     Document Type: Article

References (18)

1. Di Bella L, Rossi MT, Scalera G. Perspectives in pineal functions. In: Ariens Kappers J, Pévet P, eds. The Pineal Gland in Vertebrates including Man. Amsterdam: Elsevier North-Holland Biomedical Press; 1979:475-478.
2. Payan DG, Hess CA, Goetzl EJ. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol. 1984;84:433-438.
3. Nakamura H, Koike T, Hiruma K, et al. Identification of lymphoid cell lines bearing receptors for somatostatin. Immunology. 1987;62:655-658.
4. Hiruma K, Koike T, Nakamura H, et al. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology. 1990;71:480-485.
5. Witzig TE, Letendre L, Gerstner J, et al. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. J Clin Oncol. 1995;13:2012-2015.
6. Friesen HG, Shiu RP, Elsholtz H, et al. Prolactin and growth hormone receptors. Ciba Found Symp. 1982;90:263-278.
7. Matera L, Cutufia M, Geuna M, et al. Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. J Neuroimmunol. 1997;79:19-21.
8. Mahrle G, Thiele B. Retinoids in cutaneous T cell lymphomas. Dermatologica. 1987;175(Suppl 1):145-150.
9. Chow JM, ChengAL, Su IJ, et al. 13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma. Cancer. 1991;67:2490-2494.
10. Turley JM, Funakoshi S, Ruscetti FW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ. 1995;6:655-663.
11. Sundaresan A, Claypool K, Mehta K, et al. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas. Cell Growth Differ. 1997;8:1071-1082.
12. Konakchieva R, Kyurkchiev S, Kehayov I, et al. Selective effect of methoxyndoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol. 1995;63:125-132.
13. Vijayalaxmi, Reiter RJ, Leal BZ, et al. Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes. Mutat Res. 1996;351:187-192.
14. Viviani S, Negretti E, Orazi A, et al. Preliminary studies on melatonin in the treatment of myelodisplastic syndromes following cancer chemotherapy. J Pineal Res. 1990;8:347-354.
15. Clarke BL, Bost KL. Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes. J Immunol. 1989;143:464-469.
16. Roth JA, Kaeberle ML, Hsu WH. Effects of ACTH administration on bovine polymorfonuclear leukocyte function and lymphocyte blastogenesis. Am J Vet Res. 1982;43:412-416.
17. Todisco M, Casaccia P, Rossi N. Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non Hodgkin's Lymphomas at advanced stage: result of a phase II trial. Cancer Biotherapy Radiopharm. 2001;16:171-177.
18. Kimby E, Bjorkholm M, Gahrton G, et al. Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. Ann Oncol. 1994;5 (Suppl 2):67-71.